TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
Ontology highlight
ABSTRACT: This phase II trial studies how well TAS-102 and oxaliplatin work in treating patients with stage IV colon cancer. Drugs used in chemotherapy, such as TAS-102 and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
DISEASE(S): Stage Ivb Colon Cancer Ajcc V7,Carcinoma,Stage Iv Colon Cancer Ajcc V7,Recurrent Colon Carcinoma,Stage Iva Colon Cancer Ajcc V7,Metastatic Colorectal Carcinoma,Colorectal Neoplasms,Colonic Neoplasms,Refractory Colorectal Carcinoma
PROVIDER: 2332004 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA